Health Insider Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Insider Virgin Islands.

Press releases published on August 5, 2026

6 hours ago

STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina

Indeterminate GlobeNewswire

6 hours ago

IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid

Indeterminate GlobeNewswire

6 hours ago

BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems

Indeterminate GlobeNewswire

6 hours ago

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire

6 hours ago

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

Indeterminate GlobeNewswire

6 hours ago

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Indeterminate GlobeNewswire

6 hours ago

Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire

6 hours ago

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Indeterminate GlobeNewswire

6 hours ago

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Indeterminate GlobeNewswire

6 hours ago

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Indeterminate GlobeNewswire

6 hours ago

Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea

Indeterminate GlobeNewswire

6 hours ago

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

Indeterminate GlobeNewswire

7 hours ago

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Indeterminate GlobeNewswire

7 hours ago

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Indeterminate GlobeNewswire

7 hours ago

Nordic expands global team with new delivery capabilities to accelerate healthcare AI, analytics, managed services, and Epic support

Indeterminate GlobeNewswire

7 hours ago

ImageneBio Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

7 hours ago

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire

7 hours ago

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Indeterminate GlobeNewswire

7 hours ago

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Indeterminate GlobeNewswire

7 hours ago

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire